ArticleMicromachines2026
Microwave Metasurface-Based Sensor with Artificial Intelligence for Early Breast Tumor Detection.
Article in Micromachines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
In this paper, a microwave metasurface sensor integrated with artificial intelligence (AI) for breast tumor detection is presented. The sensor's sensitivity is estimated by analyzing shifts in magnitude and the phase of the reflection coefficient (S11) obtained from normal and abnormal breast phantoms. The (S11) responses of 137 anatomically realistic 3D numerical breast phantoms in standard classes, C1-mostly fatty, C2-scattered fibroglandular, C3-heterogeneously dense, and C4-extremely dense, incorporating different tumor sizes are used as input features. A custom neural network is developed to detect tumor presence using the recorded (S11) responses. The model is trained with cross-entropy loss and the AdamW optimizer. The dataset is split into training (70%), validation (15%), and test (15%) sets. The model achieves 99% accuracy, with perfect precision, recall, and F1-score across individual classes. For paired class combinations, accuracies of 71% (C1 with C2) and 65% (C2 with C3) are obtained, while performance degrades to approximately 50% when all four classes are combined. The sensor is fabricated and experimentally validated using two physical breast phantoms, demonstrating reliable detection of a 10 mm tumor. These results highlight the effectiveness of combining microwave metasurface sensing and AI for breast tumor detection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.